Products

Primary tabs

Export products to Excel

Displaying 31 - 45 of 209
Alternative Name: BioRings Intravaginal Ring
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Alternative Name: Carboxy Terminus Peptide of β-human chorionic gonadotropin
Development Status: Inactive
Target: Female
Mode: Non-hormonal
Project Stage: Phase II
Partner: WHO
Alternative Name: Nanocomposite Copper (Cu) IUD
Development Status: Limited Market Approval
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Marketed
Alternative Name: l’Amour®, Jeitosa®
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Partner: Cupid Ltd.
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Partner: Cupid Ltd.
Development Status: Limited Market Approval
Target: Female
Mode: Hormonal
Delivery Type: Injectable
Project Stage: Marketed
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Oral, Subdermal
Project Stage: Phase II
Alternative Name: DVD2
Development Status: Inactive
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal, Other
Project Stage: Phase I
Partner: FHI 360
Alternative Name: DMAU
Development Status: Active Development
Target: Male
Mode: Hormonal
Delivery Type: TBD
Project Stage: Phase I
Alternative Name: Depot Medroxyprogesterone Acetate (DMPA) + Testosterone
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable, Subdermal
Project Stage: Phase I
Development Status: Inactive
Target: Male
Mode: Hormonal
Delivery Type: Injectable
Alternative Name: Plasma Membrane Calcium ATPase (PMCA) Inhibitors
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel, Vaginal, Other
Alternative Name: Dapivirine (DPV) + levonorgestrel (LNG) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Development Status: Inactive
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier, Vaginal Gel
Project Stage: Phase II
Partner: ReProtect Inc.
Export to Excel